Earnings call Caplin Point posted an 11% YoY revenue growth and 21.6% PAT growth in H1 FY26, with EBITDA margin expanding to 34.1%. The company maintained strong cash reserves and guided for continued ...

Caplin Point Laboratories makes a range of branded and generic pharmaceuticals such as antibiotics, non-steroidal anti-inflammatory drugs, ophthalmic, pain management, and anti-ulcer products. Founded ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

Caplin Point Laboratories Limited posted 10% rise in net profit at Rs. 62.83 crore for the second quarter ended 30th September, 2020. The company's total revenue stood at Rs.269.88 crore. The gross ...

LIC Housing Finance (₹525): The stock is in a strong downtrend since July 2024. However, strong long-term supports are at ₹470, ₹430 and ₹400. A fall below ₹400 is unlikely. The price action over the ...

Earnings call Caplin Point delivered FY25 revenue of ₹2,034 crore, up 15% YoY, with PAT of ₹541 crore (+17% YoY), and record gross margin of 60.2%. While US growth moderated to 13%, strong execution ...